T422-0902 Screening compound: 3-{1-[6-(cyclopropylamino)pyrimidin-4-yl]piperidin-4-yl}-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]propan-1-one

T422-0902 Screening compound: 3-{1-[6-(cyclopropylamino)pyrimidin-4-yl]piperidin-4-yl}-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]propan-1-one
T422-0902 Screening compound: 3-{1-[6-(cyclopropylamino)pyrimidin-4-yl]piperidin-4-yl}-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound T422-0902
3-{1-[6-(cyclopropylamino)pyrimidin-4-yl]piperidin-4-yl}-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T422-0902

Molecular Formula

C25H41N7O (C25 H41 N7 O)

Compound Name

3-{1-[6-(cyclopropylamino)pyrimidin-4-yl]piperidin-4-yl}-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]propan-1-one

IUPAC name

3-{1-[6-(cyclopropylamino)pyrimidin-4-yl]piperidin-4-yl}-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]propan-1-one

SMILES

CN(CC1)CCC1N(CC1)CCN1C(CCC(CC1)CCN1c1ncnc(NC2CC2)c1)=O

InChI

InChI=1S/C25H41N7O/c1-29-10-8-22(9-11-29)30-14-16-32(17-15-30)25(33)5-2-20-6-12-31(13-7-20)24-18-23(26-19-27-24)28-21-3-4-21/h18-22H,2-17H2,1H3,(H,26,27,28)

InChI Key

QFGUBWVXVIERDZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27620931

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

455.65

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.550

Distribution Coefficient, logD

0.935

Water Solubility, LogSw

-2.61

Polar Surface Area

56.513

Acid Dissociation Constant (pKa)

16.66

Base Dissociation Constant (pKb)

9.00

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

80.00

T422-0902 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with T422-0902 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T422-0902?
Check Price and Availability of T422-0902, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T422-0902 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T422-0902
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T422-0902
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T422-0902 available by request